Stock Market News

Vertex passes key test in quest to treat kidney diseases

wcc wcc
Mar 10, 2026 - 15:50
0 1
Vertex passes key test in quest to treat kidney diseases
Vertex Pharmaceuticals said its drug for a rare kidney condition succeeded in a Phase 3 trial.

Previous Article

Amazon plans 'deep dive' internal meeting to address AI-related outages

Next Article

Boaz Weinstein warns of private credit’s 'financial alchemy,' says problems a...

What's Your Reaction?

Like Like 0
Dislike Dislike 0
Love Love 0
Funny Funny 0
Wow Wow 0
Sad Sad 0
Angry Angry 0
wcc
wcc

Related Posts

Why Some Retirees Pay $689.90 a Month for Medicare While Others Pay $202.90

Why Some Retirees Pay $689.90 a Month for Medicare W...

wcc
Jun 25, 2026
0
0
Gen Z shoppers are a 'tremendous opportunity': Coach and Kate Spade CEO

Gen Z shoppers are a 'tremendous opportunity': Coach...

wcc
Jun 25, 2026
0
0
Leopold Aschenbrenner’s Situational Awareness Top AI Pick-And-Shovel Stock Pick in 2026

Leopold Aschenbrenner’s Situational Awareness Top AI...

wcc
Jun 25, 2026
0
0
Capital One Financial (COF) Slipped Amid Regulatory Overhang

Capital One Financial (COF) Slipped Amid Regulatory ...

wcc
Jun 25, 2026
0
0
Does AppFolio (APPF) Have Affordable Edge Against AI Fears?

Does AppFolio (APPF) Have Affordable Edge Against AI...

wcc
Jun 25, 2026
0
0
Dollar eases from 13-month high after data burst

Dollar eases from 13-month high after data burst

wcc
Jun 25, 2026
0
0

Comments (0)

User